Please enable JavaScript to continue using this application.

Compare $MIRM vs $RYTM | Chartloom

Compare

$MIRM vs $RYTM

Mirum Pharmaceuticals Inc · Rhythm Pharmaceuticals Inc

MIRM

Mirum Pharmaceuticals Inc

RYTM

Rhythm Pharmaceuticals Inc

Compare $MIRM vs $RYTM

Comparing Mirum Pharmaceuticals Inc and Rhythm Pharmaceuticals Inc

MIRMMirum Pharmaceuticals Inc

RYTMRhythm Pharmaceuticals Inc

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

RYTMRhythm Pharmaceuticals Inc

Market cap

$6.22B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

15.08x

Rev growth (TTM)

53.5%

YTD performance

-13.6%

52W performance

-9.4%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MIRM

RYTM

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

RYTM

Rhythm Pharmaceuticals Inc

Market Cap

MIRM$5.24B

RYTM$6.22B

Enterprise Value

MIRM$5.66B

RYTM$6.26B

Price

MIRM$86.01

RYTM$90.78

P/E Ratio

MIRMN/A

RYTMN/A

P/S Ratio

MIRM8.49x

RYTM25.93x

EV/Sales

MIRM9.16x

RYTM26.10x

EV/EBITDA

MIRM2,753.41x

RYTM0.00x

P/B Ratio

MIRM22.21x

RYTM29.41x

P/FCF Ratio

MIRMN/A

RYTMN/A

EV/FCF

MIRM-21.48x

RYTM-58.90x

PEG Ratio

MIRMN/A

RYTMN/A

Forward P/E (NTM)

MIRMN/A

RYTMN/A

Forward P/S (NTM)

MIRM6.85x

RYTM15.08x

Revenue (TTM)

MIRM$618M

RYTM$240M

Revenue Growth (YoY)

MIRM44.0%

RYTM53.5%

Forward Rev Growth

MIRM17.0%

RYTM77.4%

Gross Margin (TTM)

MIRM81.7%

RYTM70.9%

Operating Margin (TTM)

MIRM0.0%

RYTM0.0%

EBITDA Margin (TTM)

MIRM-10.6%

RYTM-83.2%

Net Margin (TTM)

MIRM-139.2%

RYTM-87.6%

FCF Margin (TTM)

MIRM-42.7%

RYTM-44.3%

Net Income (TTM)

MIRM$-860M

RYTM$-210M

FCF (TTM)

MIRM$-264M

RYTM$-106M

EPS (TTM)

MIRM-$13.57

RYTM-$3.06

ROE (TTM)

MIRM-28933.0%

RYTM-8048.0%

ROA (TTM)

MIRM-9655.0%

RYTM-4400.0%

ROIC (TTM)

MIRM-13639.0%

RYTM-5656.0%

Cash

MIRM$331M

RYTM$66M

Debt

MIRM$750M

RYTM$106M

Net Cash/Debt

MIRM$-419M

RYTM$-40M

Current Ratio (TTM)

MIRM2.86x

RYTM3.45x

Quick Ratio (TTM)

MIRM2.62x

RYTM3.00x

Debt/Equity (TTM)

MIRM1.28x

RYTM0.49x

Debt/Assets (TTM)

MIRM0.0%

RYTM0.0%

Interest Coverage (TTM)

MIRMN/A

RYTMN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

RYTM0.00x

Beta

MIRM0.75

RYTM2.13

52W Performance

MIRM18.1%

RYTM-9.4%

YTD Performance

MIRM10.2%

RYTM-13.6%

% from 52W High

MIRM-33.8%

RYTM-25.7%

% from 52W Low

MIRM36.0%

RYTM21.9%

Asset Turnover (TTM)

MIRM0.69x

RYTM0.51x

FCF Yield (TTM)

MIRM-5.0%

RYTM-1.7%

Earnings Yield (TTM)

MIRM-16.4%

RYTM-3.4%

Dividend Yield (TTM)

MIRMN/A

RYTMN/A

Rule of 40

MIRM1.3

RYTM9.2

EV/GP/RG

MIRM0.45

RYTM0.49

Ticker research

View MIRM research View RYTM research

Metric	MIRM Mirum Pharmaceuticals Inc	RYTM Rhythm Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.24B	$6.22B
Enterprise Value	$5.66B	$6.26B
Price	$86.01	$90.78
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	25.93x
EV/Sales	9.16x	26.10x
EV/EBITDA	2,753.41x	0.00x
P/B Ratio	22.21x	29.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-58.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.85x	15.08x
Revenue & Growth
Revenue (TTM)	$618M	$240M
Revenue Growth (YoY)	44.0%	53.5%
Forward Rev Growth	17.0%	77.4%
Profitability
Gross Margin (TTM)	81.7%	70.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.6%	-83.2%
Net Margin (TTM)	-139.2%	-87.6%
FCF Margin (TTM)	-42.7%	-44.3%
Net Income (TTM)	$-860M	$-210M
FCF (TTM)	$-264M	$-106M
EPS (TTM)	-$13.57	-$3.06
ROE (TTM)	-28933.0%	-8048.0%
ROA (TTM)	-9655.0%	-4400.0%
ROIC (TTM)	-13639.0%	-5656.0%
Financial Health
Cash	$331M	$66M
Debt	$750M	$106M
Net Cash/Debt	$-419M	$-40M
Current Ratio (TTM)	2.86x	3.45x
Quick Ratio (TTM)	2.62x	3.00x
Debt/Equity (TTM)	1.28x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	2.13
52W Performance	18.1%	-9.4%
YTD Performance	10.2%	-13.6%
% from 52W High	-33.8%	-25.7%
% from 52W Low	36.0%	21.9%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.51x
FCF Yield (TTM)	-5.0%	-1.7%
Earnings Yield (TTM)	-16.4%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	9.2
EV/GP/RG	0.45	0.49
Ticker research	View MIRM research	View RYTM research

Valuation

P/S Ratio

MIRM

8.49x

RYTM

25.93x

EV/FCF

RYTM

-58.90x

MIRM

-21.48x

Growth & revenue

Revenue Growth TTM

RYTM

53.5%

MIRM

44.0%

Forward Revenue Growth

RYTM

77.4%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

RYTM

70.9%

ROE

RYTM

-8048.0%

MIRM

-28933.0%

FCF Yield %

RYTM

-1.7%

MIRM

-5.0%

52-Week Performance

MIRM

18.1%

RYTM

-9.4%

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

RYTM

Rhythm Pharmaceuticals Inc

Market Cap

MIRM$5.24B

RYTM$6.22B

Enterprise Value

MIRM$5.66B

RYTM$6.26B

Price

MIRM$86.01

RYTM$90.78

P/E Ratio

MIRMN/A

RYTMN/A

P/S Ratio

MIRM8.49x

RYTM25.93x

EV/Sales

MIRM9.16x

RYTM26.10x

EV/EBITDA

MIRM2,753.41x

RYTM0.00x

P/B Ratio

MIRM22.21x

RYTM29.41x

P/FCF Ratio

MIRMN/A

RYTMN/A

EV/FCF

MIRM-21.48x

RYTM-58.90x

PEG Ratio

MIRMN/A

RYTMN/A

Forward P/E (NTM)

MIRMN/A

RYTMN/A

Forward P/S (NTM)

MIRM6.85x

RYTM15.08x

Revenue (TTM)

MIRM$618M

RYTM$240M

Revenue Growth (YoY)

MIRM44.0%

RYTM53.5%

Forward Rev Growth

MIRM17.0%

RYTM77.4%

Gross Margin (TTM)

MIRM81.7%

RYTM70.9%

Operating Margin (TTM)

MIRM0.0%

RYTM0.0%

EBITDA Margin (TTM)

MIRM-10.6%

RYTM-83.2%

Net Margin (TTM)

MIRM-139.2%

RYTM-87.6%

FCF Margin (TTM)

MIRM-42.7%

RYTM-44.3%

Net Income (TTM)

MIRM$-860M

RYTM$-210M

FCF (TTM)

MIRM$-264M

RYTM$-106M

EPS (TTM)

MIRM-$13.57

RYTM-$3.06

ROE (TTM)

MIRM-28933.0%

RYTM-8048.0%

ROA (TTM)

MIRM-9655.0%

RYTM-4400.0%

ROIC (TTM)

MIRM-13639.0%

RYTM-5656.0%

Cash

MIRM$331M

RYTM$66M

Debt

MIRM$750M

RYTM$106M

Net Cash/Debt

MIRM$-419M

RYTM$-40M

Current Ratio (TTM)

MIRM2.86x

RYTM3.45x

Quick Ratio (TTM)

MIRM2.62x

RYTM3.00x

Debt/Equity (TTM)

MIRM1.28x

RYTM0.49x

Debt/Assets (TTM)

MIRM0.0%

RYTM0.0%

Interest Coverage (TTM)

MIRMN/A

RYTMN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

RYTM0.00x

Beta

MIRM0.75

RYTM2.13

52W Performance

MIRM18.1%

RYTM-9.4%

YTD Performance

MIRM10.2%

RYTM-13.6%

% from 52W High

MIRM-33.8%

RYTM-25.7%

% from 52W Low

MIRM36.0%

RYTM21.9%

Asset Turnover (TTM)

MIRM0.69x

RYTM0.51x

FCF Yield (TTM)

MIRM-5.0%

RYTM-1.7%

Earnings Yield (TTM)

MIRM-16.4%

RYTM-3.4%

Dividend Yield (TTM)

MIRMN/A

RYTMN/A

Rule of 40

MIRM1.3

RYTM9.2

EV/GP/RG

MIRM0.45

RYTM0.49

Ticker research

View MIRM research View RYTM research

Metric	MIRM Mirum Pharmaceuticals Inc	RYTM Rhythm Pharmaceuticals Inc
Market & Valuation
Market Cap	$5.24B	$6.22B
Enterprise Value	$5.66B	$6.26B
Price	$86.01	$90.78
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	25.93x
EV/Sales	9.16x	26.10x
EV/EBITDA	2,753.41x	0.00x
P/B Ratio	22.21x	29.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-58.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.85x	15.08x
Revenue & Growth
Revenue (TTM)	$618M	$240M
Revenue Growth (YoY)	44.0%	53.5%
Forward Rev Growth	17.0%	77.4%
Profitability
Gross Margin (TTM)	81.7%	70.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.6%	-83.2%
Net Margin (TTM)	-139.2%	-87.6%
FCF Margin (TTM)	-42.7%	-44.3%
Net Income (TTM)	$-860M	$-210M
FCF (TTM)	$-264M	$-106M
EPS (TTM)	-$13.57	-$3.06
ROE (TTM)	-28933.0%	-8048.0%
ROA (TTM)	-9655.0%	-4400.0%
ROIC (TTM)	-13639.0%	-5656.0%
Financial Health
Cash	$331M	$66M
Debt	$750M	$106M
Net Cash/Debt	$-419M	$-40M
Current Ratio (TTM)	2.86x	3.45x
Quick Ratio (TTM)	2.62x	3.00x
Debt/Equity (TTM)	1.28x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	2.13
52W Performance	18.1%	-9.4%
YTD Performance	10.2%	-13.6%
% from 52W High	-33.8%	-25.7%
% from 52W Low	36.0%	21.9%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.51x
FCF Yield (TTM)	-5.0%	-1.7%
Earnings Yield (TTM)	-16.4%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	9.2
EV/GP/RG	0.45	0.49
Ticker research	View MIRM research	View RYTM research